| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/13/2010 | EP2142193A2 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2010 | EP2142184A1 Use of s1p receptor modulator |
| 01/13/2010 | EP2142182A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission |
| 01/13/2010 | EP2141989A1 Compositions and methods for prophylaxis and treatment of addictions |
| 01/13/2010 | EP1987029B1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 01/13/2010 | EP1869018B1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands |
| 01/13/2010 | EP1641805B1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 01/13/2010 | EP1558749B1 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1451160B1 Pyrazole-amides for use in the treatment of pain |
| 01/13/2010 | EP1305322B1 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 01/13/2010 | EP1211242B1 Prostaglandin derivatives |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624372A Lactam compound |
| 01/13/2010 | CN100580079C Neural progenitor cell populations |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579979C 7-phenylpyrazolopyridine compounds |
| 01/13/2010 | CN100579975C Process for preparing duloxetine and intermediates for use therein |
| 01/13/2010 | CN100579579C Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/13/2010 | CN100579574C Brain protein hydrolyte freeze-drying preparation for injection and its making method |
| 01/13/2010 | CN100579572C Orally-administered Chinese medicinal composition for treating migraine pain |
| 01/13/2010 | CN100579556C Preparation method of Chinese medicinal capsule for treating apoplexy |
| 01/13/2010 | CN100579545C Health-care wine with sleeping improving and beauty functions and its preparing process |
| 01/13/2010 | CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder |
| 01/13/2010 | CN100579519C Use of patchouli alcohol in preparing medicament for preventing and controlling senile dementia |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645890 Process for preparing duloxetine and intermediates for use therein |
| 01/12/2010 | US7645887 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645601 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 01/12/2010 | US7645465 Includes acid-treatment of ginseng and bio-converting treatment, such as lactic acid bacterial fermenting and intestinal bacterial fermenting process, extracting acid treated ginseng with organic solvent to obtain organic extract, fermenting organic extract with lactic-acid bacteria Bifidobacterium KK-1 |
| 01/12/2010 | US7645446 Glutamic acid decarboxylase (GAD) based delivery system |
| 01/12/2010 | CA2573404C Substituted oxindole derivatives and medicaments containing the same |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2384018C Muscarinic antagonists |
| 01/12/2010 | CA2373281C Methods of treating diabetes using a complex of igf-1 and igfbp-3 |
| 01/12/2010 | CA2324339C Piperidine derivatives |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/12/2010 | CA2276373C Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010003084A2 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | WO2010003046A2 Gabapentin enacarbil salts and processes for their preparation |
| 01/07/2010 | WO2010002971A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 01/07/2010 | WO2010002802A1 Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |
| 01/07/2010 | WO2010002472A1 Jak kinase modulating compounds and methods of use thereof |
| 01/07/2010 | WO2010002451A1 Naphthyridin derivatives |
| 01/07/2010 | WO2010002209A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2010001167A2 Novel process |
| 01/07/2010 | WO2010000763A2 Combination products |
| 01/07/2010 | WO2010000748A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 01/07/2010 | WO2010000429A1 Adenine receptor ligands |
| 01/07/2010 | WO2010000353A1 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 01/07/2010 | WO2010000198A1 Benzothiophene alkanol piperazine derivatives and their use as antidepressant |
| 01/07/2010 | WO2010000196A1 Method for chemical synthesis of oxcarbazepine |
| 01/07/2010 | WO2010000089A1 Stat3 and tyk2 as drug targets for neurodegenerative diseases |
| 01/07/2010 | WO2010000073A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity |
| 01/07/2010 | WO2010000019A1 Pain-relieving compositions of furoxan no donors and uses thereof |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009138734A3 Use of opioid compounds in peripheral pain, wound healing and scar formation |
| 01/07/2010 | WO2009129259A3 Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor |
| 01/07/2010 | WO2009120815A9 Therapeutic compositions and methods |
| 01/07/2010 | WO2009120390A3 Cyclopropanated carbohydrates |
| 01/07/2010 | WO2009120368A3 Treatment of brain damage using umbilical cord blood cells |
| 01/07/2010 | WO2009117480A3 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/07/2010 | WO2009117041A3 Use of pyrene to carry peptides across the blood brain barrier |
| 01/07/2010 | WO2009112691A3 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 01/07/2010 | WO2009090556A3 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors |
| 01/07/2010 | WO2007133886A3 Herbal formulation for treatment of depression and other related disorders and method of preparing the same |
| 01/07/2010 | US20100004433 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/07/2010 | US20100004340 Naphthyl(ethyl) acetamides |
| 01/07/2010 | US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| 01/07/2010 | US20100004336 comprising L-lysine-d-amphetamine hydrochloride salt; without spiking blood serum concentrations of amphetamine; sustained release; for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability; reducing oral abuse liability |
| 01/07/2010 | US20100004332 Levodopa Prodrugs, and Compositions and Uses Thereof |
| 01/07/2010 | US20100004310 Pharmaceutical formulations for the treatment of alzheimer's disease |
| 01/07/2010 | US20100004302 Methods for Treating Degenerative Diseases/Injuries |
| 01/07/2010 | US20100004300 voltage-gated sodium channel inhibitors such as 4-[(3S,3'R)-3-(3,5-dichlorophenyl)-2'-oxo-1,3'-bipyrrolidin-1'-yl)]-N-(thiazol-2-yl)benzenesulfonamide, used for the treatment of neuropathic or inflammatory pain, arthritis, headaches, neuralgia, epilepsy, neurodegenerative or psychiatric disorders |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004294 Stable Lozenge Compositions Providing Rapid Release of Nicotine |
| 01/07/2010 | US20100004289 Substituted butyrophenone derivatives |
| 01/07/2010 | US20100004286 Novel isoindolinone derivatives having inhibitory activity against t-type calcium channel and method for preparation thereof |
| 01/07/2010 | US20100004284 Novel Heterocyclic Compounds as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 01/07/2010 | US20100004283 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 01/07/2010 | US20100004278 Dextromethorphan hydrochloride |
| 01/07/2010 | US20100004265 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 01/07/2010 | US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |